About our clients

We’ve advised most of the world’s top biopharmaceutical companies, alongside fast-growing health tech companies and leading patient organisations.

You’re the perfect client for us if….

  1. You want to transform your organisation’s challenges into opportunities
  2. You are tired of hearing the same old ideas and want to inject creative solutions into your organisational DNA
  3. You want to work with consultants who are curious
  4. You like working with kind consultants (seriously, this is a role requirement in our job adverts!)

  • Amazing. I would recommend OVID to anyone. Clear, strategic, very informed advice and a pleasure to work with. OVID really did make it possible to run an impactful campaign and kept us on track, focused and without panic.

    Athena Lamnisos
    Chief Executive / The Eve Appeal

  • I was impressed by how quickly OVID got to know our business and how they helped us define our narrative as a company. Their strategic advice on messaging, the design of our IR slides, and our website was spot on, exactly what we needed to make an impression on potential investors and customers.

    Dr Lorin Gresser
    CEO / DemDX

  • OVID’s public affairs team continually provide us with insightful and impactful support to help drive our policy engagement.

    Aaron Gowson
    Head of Public Affairs UK / Chiesi Ltd

  • “OVID Health is an agency with exciting ideas and is not afraid to lead from the front, and with the Cell & Gene Collective, they have done just that. OVID brought together industry leaders and developed a strategy that brought a new impetus to the cell and gene therapy landscape with a strong patient centric ethos.”

    Anita Ralli
    Director of Government Affairs / Gilead

  • "OVID helped us develop our patient engagement strategy and I found working with the team on this really refreshing. They’re well organised and listened carefully to our challenges before creating a plan. I was impressed with the efficiency of their execution, particularly how they gathered insights across the organisation. I’m really pleased with what we have now, which is a very clear, solid and workable strategy. Thank you."

    Ian Stiles
    Director of Rare Blood Disorders/ Novo Nordisk

Client Case Studies

We partnered with Roche, Macular Society and Fight for Sight to form ‘The Eyes Have It’ partnership. The partnership set out with a specific goal: to build new advocates for sight loss resulting in executive buy-in at NHS England-level to create system change. We would......

06 August, 2021

We supported Sanofi UK to develop and deliver their patient advocacy strategy. This involved strengthening Sanofi’s relationships with patient groups, helping patient groups to build their capability on policy issues and delivering an employee engagement programme to improve understanding in the important work Sanofi does......

24 March, 2021

The Cell & Gene Collective was set up by OVID Health in 2020. It is an alliance of eight biopharmaceutical companies who wish to support the NHS and policymakers in delivering appropriately assessed, commissioned, and delivered cell and gene therapies to patients (including oncology patients).......

12 March, 2021

Our award-nominated ‘Educating Eve’ integrated campaign supplied advice for women on gynaecological cancers. Using YouGov results from an exclusive poll we gained exceptional national media coverage across broadcast and print, as well as celebrity endorsements and follow-up features....

12 March, 2021

We raised this health tech company’s profile and built corporate value to attract US investors as it prepared for upcoming capital raises. Our support included developing a high-impact corporate narrative to be used across all communications materials, advising on and creating content for the website......

12 March, 2021

We lead MedCity’s external affairs strategy, calling for ongoing investment in London’s global life sciences powerhouse, underpinned by a media relations, high-level stakeholder engagement programme and influencing support. We have supported them to influence the national life sciences sector recovery roadmap and helped to form......

12 March, 2021

Clients